Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 278 No 7455 p666
9 June 2007

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Folic acid supplements can reduce risk of stroke

Macsek/Dreamstime.com

Folic acid fortification of bread or flour

FSA is poised to recommend folic acid fortification of bread or flour

Folic acid supplementation can reduce the risk of stroke in those with no history of the disease, according to research published in The Lancet (2007;369:1876). A second study published this week indicates that folic acid supplementation is of no benefit for secondary prevention of colo-rectal adenomas, and may increase the risk of some types of colorectal tumours (JAMA 2007;297:2351).

In the Lancet study, researchers conducted a meta-analysis of eight randomised controlled trials involving 16,841 participants, which compared folic acid supplementation (with or without other B vitamins) with placebo, a lower dose of folic acid or usual care for a minimum of six months. Dose of folic acid ranged from 0.5mg per day to 15mg per day. Stroke was reported as one of the endpoints.

The analysis showed that folic acid supplementation reduced the risk of stroke by 18 per cent (relative risk 0.82, 95 per cent confidence interval 0.68–1.00; P=0.045). Further stratified analyses showed that greater benefit was seen in the trials in which participants had no history of stroke (0.75, 0.62–0.90; P=0.002), supplements were given for more than 36 months (0.71, 0.57–0.87; P=0.001), homocysteine levels were reduced by more than 20 per cent (0.77, 0.63–0.94; P=0.012) and participants lived in countries without grain fortification (0.75, 0.62–0.91; P=0.003).

“Our meta-analysis provides coherent evidence that folic acid supplementation can significantly reduce the risk of stroke in primary prevention,” the researchers say. However, they acknowledge that there is continued controversy over whether folic acid supplementation can lead to improved outcomes for other cardiovascular endpoints, with some trials yielding negative results.

The JAMA study was a randomised controlled trial of 1,021 adults with a recent history of colorectal adenomas (a precursor to colorectal cancer), who received folic acid 1mg daily or placebo (with or without aspirin).

During the first three years, the incidence of at least one colorectal adenoma was similar in the folic acid and placebo groups (44.1 per cent versus 42.4 per cent; P=0.58), as was the incidence of at least one advanced lesion (11.4 per cent versus 8.6 per cent; P=0.15). Three to five years later, the incidence of at least one colorectal adenoma was similar in the two groups but the incidence of at least one advanced lesion was higher in the folic acid group (11.6 per cent versus 6.9 per cent; P=0.05). Folic acid was also associated with higher risks of having three or more adenomas and of non-colorectal cancers.

Mandatory fortification The Food Standards Agency is to recommend mandatory fortification of food with folic acid to UK health ministers as part of a package of measures to help prevent neural tube defects. At its meeting in Nottingham last month, the board asked for further work to consider whether folic acid should be added to either bread or flour and agreed that controls on voluntary fortification were an essential part of its recommendation.

Back to Top


©The Pharmaceutical Journal